Evaluation on predictive value of serum HBsAg,HBcrAg and HBV DNA for liver pathology in chronic hepatitis B patients
Zhan-qing ZHANG,Wei LU,Rong-rong DING,Qi-cheng WENG,Zhi-yong ZHANG,Yan-bing WANG,Xin-lan ZHOU,Dan HUANG,Xiu-fen LI
DOI: https://doi.org/10.14000/j.cnki.issn.1008-1704.2016.10.002
2016-01-01
Abstract:Objective To evaluate the predictive value of serum hepatitis B surface antigen (HBsAg),hepatitis B core-related antigen (HBcrAg)and hepatitis B virus (HBV)DNA for liver pathology in chronic hepatitis B (CHB)patients. Methods CHB patients,containing 324 HBeAg-positive and 255 HBeAg-negative cases,were randomly divided into 3 paired train and validation sets.Serum HBsAg and HBcrAg were measured by Lumipulse G1200 and Abbott Architect I2000 automatic chemiluminescence immunoassay analyzers,respectively.Serum HBV DNA was detected by Bio-Rad Icycler fluorescence quantitative PCR system.Scheuer scoring system was applied for pathological evaluation of liver tissues,containing 5 grades from G0 to G4 and 5 stages from S0 to S4.Results Gender ratio,average age and proportion of pathological grades and stages in 3 paired train and validation sets showed no statistically significant differences (P >0.05)in both HBeAg positive and negative cases.In HBeAg-positive patients, the areas under receiver operating characteristic curve (ROC)of serum HBsAg,HBcrAg and HBV DNA for predicting ≥ G3 and ≥ S4 in complete set were the largest.Referring to the optimal cutoffs for predicting ≥ G3 and ≥ S4 in 3 train sets,the ranges of sensitivities of serum HBsAg,HBcrAg and HBV DNA for predicting ≥ G3 and ≥ S4 in the 3 matched validation sets were 37%,30%, 17% and 9%,16%,14%,respectively.Meanwhile,the ranges of specificity were 12%,13%,15% and 5%,3%,6%, <br> respectively.In HBeAg-negative patients,the areas under ROC of serum HBcrAg and HBV DNA for predicting ≥ G2 and≥ S2 in complete set were the largest.Based on the optimal cutoffs in 3 train sets,the ranges of sensitivity of serum HBcrAg and HBV DNA for predicting ≥ G2 and ≥ S2 in the 3 matched validation sets were 11 %,46% and 19%,20%, respectively,and the ranges of specificities were 15%,38% and 2%,16%,respectively.Conclusion In HBeAg-positive patients,serum HBsAg,HBcrAg and HBV DNA were suitable for predicting pathologic states of ≥ G3 and ≥ S4,and the stabilities for predicting ≥ S4 were better than those for predicting ≥ G3.In HBeAg-negative patients with pathologic states of ≥ G2 and ≥ S2,serum HBcrAg and HBV DNA were the best predictable indicators,and serum HBcrAg showed better stabilities than serum HBV DNA.